Health-related quality of life (HRQoL) in ACIS: A phase III trial of apalutamide with abiraterone acetate and prednisone (APA + AAP) vs AAP in metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Oudard, S. M.; Bevans, K. B.; Attard, G.; Efstathiou, E.; Flaig, T. W.; Franke, F. A.; Goodman, O. B. Jr; De Giorgi, U.; Pieczonka, C. M.; Yeruva, K.; De Porre, P.; Brookman-May, S. D.; Dibaj, S.; Wu, D.; Mundle, S. D.; McCarthy, S.; Steuber, T.; Suzuki, H.; Rathkopf, D. E.; Saad, F. |
| Abstract Title: | Health-related quality of life (HRQoL) in ACIS: A phase III trial of apalutamide with abiraterone acetate and prednisone (APA + AAP) vs AAP in metastatic castration-resistant prostate cancer (mCRPC) |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S634 |
| Language: | English |
| ACCESSION: | WOS:000700527701048 |
| DOI: | 10.1016/j.annonc.2021.08.1097 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 584P -- Source: Wos |
